﻿<?xml version="1.0" encoding="utf-8"?><?xml-stylesheet title="XSL_formatting" type="text/xsl" href="cms1260795.aspx"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><language>en-gb</language><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><lastBuildDate>Tue, 06 Jan 2009 15:04:02 GMT</lastBuildDate><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><description><![CDATA[aidsmap.com news feed : aidsmap news]]></description><copyright>Copyright NAM 2008</copyright><link>http://www.aidsmap.com</link><atom:link href="http://www.aidsmap.com/cms1260794.aspx" rel="self" type="application/rss+xml" /><image><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><url>http://www.aidsmap.com/files/file1002517.gif</url><link>http://www.aidsmap.com</link><width>122</width><height>44</height></image><ttl>15</ttl><item><title><![CDATA[Lack of perceived need for HIV treatment associated with poor adherence]]></title><link>http://www.aidsmap.com/en/news/0571EA7C-7B32-4C2A-9B5D-221343928684.asp</link><author>Michael Carter</author><guid isPermaLink="false">0571EA7C-7B32-4C2A-9B5D-221343928684</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Patients who do not think they need antiretroviral therapy have poorer adherence to such treatment, Dutch investigators report in the December 1st edition of the Journal of Acquired Immune Deficiency Syndromes. The investigators also found that a higher CD4 cell count was associated with a lower perceived necessity to start HIV treatment and theycomment “this finding…is relevant for the debate regarding the possibility of starting earlier with [antiretroviral therapy], that is, at a CD4 cell count of 500 cells per microliter.”
]]></description><category>Adherence news</category><category>Starting treatment news</category></item><item><title><![CDATA[TB doesn't always increase HIV viral load]]></title><link>http://www.aidsmap.com/en/news/74FB86D5-5BCD-400F-A8A7-267F075D704B.asp</link><author>Michael Carter</author><guid isPermaLink="false">74FB86D5-5BCD-400F-A8A7-267F075D704B</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[A quarter of Ugandan HIV-positive patients with active tuberculosis (TB) had a viral load below 10,000 copies/ml, investigators report in a letter published in the December 1st edition of the Journal of Acquired Immune Deficiency Syndromes. Furthermore, the investigators found that viral load increased in a significant proportion of patients whose viral load was below 1000 copies/ml after they started treatment with anti-TB drugs.
]]></description><category>Africa news</category><category>Tuberculosis news</category></item><item><title><![CDATA[New 75mg darunavir tablet approved by FDA for use by HIV-positive children]]></title><link>http://www.aidsmap.com/en/news/510351C1-B9D5-484B-B9F7-2BCA26B45306.asp</link><author>Michael Carter</author><guid isPermaLink="false">510351C1-B9D5-484B-B9F7-2BCA26B45306</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Drug regulatory authorities in the US have approved a new 75mg darunavir (Prezista tablet for paediatric use. 
]]></description><category>New drugs news</category><category>Children and HIV news</category></item><item><title><![CDATA[Thyroid checks recommended for people with HIV]]></title><link>http://www.aidsmap.com/en/news/EBC26DAC-C874-4B44-B182-BFA9B21F6E24.asp</link><author>Michael Carter</author><guid isPermaLink="false">EBC26DAC-C874-4B44-B182-BFA9B21F6E24</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Patients receiving HIV treatment should have routine tests to check thyroid function, doctors from the UK recommend in an article published in the January 1st  edition of the Journal of Acquired Immune Deficiency Syndromes. Investigators from London’s Chelsea and Westminster Hospital found “a higher than expected incidence of hypothyroidism” (an under-active thyroid gland) amongst their patients. 
]]></description><category>Medical tests news</category></item><item><title><![CDATA[Knighthood for head of UK HIV charity]]></title><link>http://www.aidsmap.com/en/news/E8FCD748-C685-4E90-A832-C4E5A50EFC88.asp</link><author>Michael Carter</author><guid isPermaLink="false">E8FCD748-C685-4E90-A832-C4E5A50EFC88</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Nick Partridge, head of the UK’s largest HIV charity has received a knighthood in the New Year’s Honours.
]]></description><category>UK news</category></item><item><title><![CDATA[Gay men often not accessing PEP despite risk of HIV exposure]]></title><link>http://www.aidsmap.com/en/news/4B5B88F8-7140-457B-AFC8-CC7C9EA25ABA.asp</link><author>Michael Carter</author><guid isPermaLink="false">4B5B88F8-7140-457B-AFC8-CC7C9EA25ABA</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Gay men may not be accessing HIV post-exposure prophylaxis (PEP) in situations when its use would be warranted, a study published in the online edition of Sexually Transmitted Infections suggests. 
]]></description><category>UK news</category><category>Gay men news</category><category>Prevention news</category></item><item><title><![CDATA[Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV]]></title><link>http://www.aidsmap.com/en/news/025FC859-1838-422E-97CA-F503636D4E4B.asp</link><author>Kelly Safreed-Harmon</author><guid isPermaLink="false">025FC859-1838-422E-97CA-F503636D4E4B</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[A study published in the December 15th edition of the Journal of Acquired Immune Deficiency Syndromes has provided further insight into the relationship between HIV and heart disease by examining factors associated with endothelial activation. The study found higher than normal endothelial activation levels in HIV-positive people who are not taking antiretroviral therapy, but there was no evidence of an association between endothelial activation and lipoatrophy, which other researchers have suggested may be a risk factor for heart disease in HIV-positive people.
]]></description><category>Lipodystrophy news</category></item><item><title><![CDATA[Internalised homophobia leads to sexual risk taking by HIV-positive gay men]]></title><link>http://www.aidsmap.com/en/news/0B02B1E9-8CD0-4C9D-8E79-512A8583F1E9.asp</link><author>Michael Carter</author><guid isPermaLink="false">0B02B1E9-8CD0-4C9D-8E79-512A8583F1E9</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Internalised homophobia is associated with sexual risk behaviour amongst HIV-positive gay and bisexual men, US research published in the journal AIDS Education and Prevention suggests. The investigators found that not being “out” as gay or bisexual was associated with non-disclosure of HIV status to non-primary sexual partners and that lower sexual comfort was associated with less confidence using condoms and unprotected anal sex with HIV-negative men or men of an unknown HIV status. 
]]></description><category>Gay men news</category><category>Prevention news</category></item><item><title><![CDATA[Most gay men willing to consider PrEP for possible HIV exposure]]></title><link>http://www.aidsmap.com/en/news/94F4FFC4-28A4-4515-9C26-7605B7676E41.asp</link><author>Michael Carter</author><guid isPermaLink="false">94F4FFC4-28A4-4515-9C26-7605B7676E41</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Three-quarters of gay and other men who have sex with men would be willing to take pre-exposure prophylaxis to prevent HIV infection, American researchers report in the January 1st 2009 edition of the Journal of Acquired Immune Deficiency Syndromes. The investigators hope their research will help identify men willing to participate in pre-exposure prophylaxis studies or who would benefit from pre-exposure prophylaxis programmes. 
]]></description><category>Gay men news</category><category>Prevention news</category></item><item><title><![CDATA[Male circumcision doesn't protect against urethral STIs]]></title><link>http://www.aidsmap.com/en/news/E364F366-7B70-4A16-A09D-98944B22273C.asp</link><author>Michael Carter</author><guid isPermaLink="false">E364F366-7B70-4A16-A09D-98944B22273C</guid><pubDate>Tue, 06 Jan 2009 15:04:02 GMT</pubDate><image /><description><![CDATA[Circumcision does not protect men against urethral infection with the bacterial sexually transmitted infections gonorrhoea and chlamydia, according to the results of a randomised controlled trial published in the online edition of Sexually Transmitted Infections. However, the study showed that male circumcision offered some protection against trichomonas vaginalis and the investigators suggest that this could be one of the reasons why circumcision provides some protection against infection with HIV. 
]]></description><category>Africa news</category><category>Prevention news</category></item></channel></rss>